Form 4 for IMUX IMMUNIC, INC.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-10 · accession 0001193805-21-001163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-11 | 2021-08-10 | IMUX | Whaley Glenn | PFO, PAO | P - Purchase | $9.85 | +1,500 | 3,500 | +75% | +$14.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | P | A | 1,500 | $9.85 | 3,500 | D | — | — | (F1) Reflects the weighted average price of 1,500 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on August 10, 2021 at prices ranging from $9.65 to $9.95 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |